Abnormal energetics and ATP depletion in pressure-overload mouse hearts: In vivo high-energy phosphate concentration measures by noninvasive magnetic resonance

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 297, Issue 1, 2009, Pages

  Gupta, Ashish ^a   Chacko, V P ^a   Weiss, Robert G ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Adenosine 5 triphosphate; Hypertrophy; Magnetic resonance spectroscopy; Phosphocreatine

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE;

ANIMAL EXPERIMENT; AORTA CONSTRICTION; ARTICLE; ENERGY METABOLISM; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE PRESSURE; HIGH ENERGY PHOSPHATE; MALE; MOUSE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; THORACIC AORTA;

ADENOSINE TRIPHOSPHATE; ALGORITHMS; ANIMALS; CONSTRICTION; ENERGY METABOLISM; HEART; HUMANS; LUMINESCENCE; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MYOCARDIUM; PHOSPHOCREATINE; PRESSURE; SPECIES SPECIFICITY; THORAX;

EID: 67650095388     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00178.2009     Document Type: Article

References (32)

1. 31P NMR data (Abstract). Soc Magn Reson Med 9: 1089, 1990.
2. Beer M, Seyfarth T, Sandstede J, Landschutz W, Lipke C, Kostler H, Kienlin VM, Harre K, Hahn D, Neubauer S. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured non-invasively with 31P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 40: 1267-1274, 2002.
3. Bottomley PA, Atalar E, Weiss RG. Human cardiac high-energy phosphate metabolite concentrations by 1D-resolved NMR spectroscopy. Magn Reson Med 35: 664-670, 1996.
4. Bottomley PA, Hardy CJ, Roemer PB. Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance. Magn Reson Med 14: 425-434, 1990.
5. 31P spectroscopy. The definition of localized volumes, dealing with saturation and the technique-dependence of quantification. NMR Biomed 20: 284-289, 1989.
6. Chacko VP, Aresta F, Chacko SM, Weiss RG. MRI/MRS assessment of in vivo murine cardiac metabolism, morphology, and function at physiological heart rates. Am J Physiol Heart Circ Physiol 279: H2218-H2224, 2000.
7. 31P magnetic resonance spectroscopy. Lancet 338: 973-976, 1991.
8. Flaherty JT, Weisfeldt ML, Bulkley BH, Gardner TJ, Gott VL, Jacobus WE. Mechanisms of ischemic myocardial cell damage assessed by phosphorus-31 nuclear magnetic resonance. Circulation 65: 561-571, 1982.
9. Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 122: 795-801, 1991.
10. Hove MT, Lygate CA, Fischer A, Schneider JE, Sang AE, Hulbert K, Montefiore LS, Watkins H, Clarke K, Isbrandt D, Wallis J, Neubauer S. Reduced inotropic reserve and increased susceptibility to cardiac ischemia/reperfusion injury in phosphocreatine-deficient guanidinoacetate-N- methyltransferase-knockout mice. Circulation 111: 2477-2485, 2005.
11. Ingwall JS. Phosphorus nuclear magnetic resonance spectroscopy of cardiac and skeletal muscles. Am J Physiol Heart Circ Physiol 242: H729-H744, 1982.
12. Ingwall JS, Weiss RG. Is the failing heart energy starved? On using chemical energy to support cardiac function. Circ Res 95: 135-145, 2004.
13. Jacobus WE, Taylor GJ, Hollis DP, Nunnally RL. Phosphorus nuclear magnetic resonance of perfused working rat hearts. Nature 265: 756-758, 1977.
14. Maslov MY, Chacko VP, Stuber M, Moens AL, Kass DA, Champion HC, Weiss RG. Altered high energy phosphate metabolism predicts contractile dysfunction and subsequent ventricular remodeling in pressure-overload hypertrophy mice. Am J Physiol Heart Circ Physiol 292: H387-H391, 2007.
15. 31P NMR spectroscopy. Magn Reson Med 41: 657-663, 1999.
16. 31P nuclear magnetic resonance spectroscopy in patients with old myocardial infarction. Jpn Circ J 56: 614-619, 1992.
17. 31P NMR spectroscopy. Am J Physiol Heart Circ Physiol 285: H1976-H1979, 2003.
18. Neubauer S. The failing heart - an engine out of fuel. N Engl J Med 356: 1140-1151, 2007.
19. Neubauer S, Beer M, Landschütz W, Sandstede J, Seyfarth T, Lipke C, Köstler H, Pabst T, Kenn W, Meininger M, von Kienlin M, Horn M, Harre K, Hahn D. Absolute quantification of high energy phosphate metabolites in normal, hypertrophied and failing human myocardium. MAGMA 11: 73-74, 2000.
20. 31P MRS. Magn Reson Med 39: 772-782, 1998.
21. Opasich C, Aquilani R, Dossena M, Foppa P, Catapano M, Pagani S, Pasini E, Ferrari R, Tavazzi L, Pastoris O. Biochemical analysis of muscle biopsy in overnight fasting patients with severe chronic heart failure. Eur Heart J 17: 1686-1693, 1996.
22. Pinz I, Ostroy SE, Hoyer K, Osinska H, Robbins J, Molkentin JD, Ingwall JS. Calcineurin-induced energy wasting in a transgenic mouse model of heart failure. Am J Physiol Heart Circ Physiol 294: H1459-H1466, 2008.
23. Ronner P, Friel E, Czerniawski K, Frankle S. Luminometric assays of ATP, phosphocreatine, and creatine for estimation of free ADP and free AMP. Anal Biochem 275: 208-216, 1999.
24. Saupe KW, Spindler M, Hopkins JC, Shen W, Ingwall JS. Kinetic, thermodynamic, and developmental consequences of deleting creatine kinase isoenzymes from the heart. Reaction kinetics of the creatine kinase isoenzymes in the intact heart. J Biol Chem 275: 19742-19746, 2000.
25. Shen W, Asai K, Uechi M, Mathier MA, Shannon RP, Vatner SF, Ingwall JS. Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs. Circulation 100: 2113-2118, 1999.
26. Smith CS, Bottomley PA, Schulman SP, Gerstenblith G, Weiss RG. Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium. Circulation 114: 1151-1158, 2006.
27. Taha M, Lopaschuk GD. Alterations in energy metabolism in cardiomyopathies. Ann Med 39: 594-607, 2007.
28. Weiss RG, Bottomley PA, Hardy CJ, Gerstenblith G. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med 323: 1593-1600, 1990.
29. Weiss RG, Gerstenblith G, Bottomley PA. ATP Flux through creatine kinase in the normal, stressed and failing human heart. Proc Natl Acad Sci USA 1002: 808-813, 2005.
30. 31P magnetic resonance spectroscopy. Circulation 92: 15-23, 1995.
31. Ye Y, Gong G, Ochiai K, Liu J, Zhang J. High-energy phosphate metabolism and creatine kinase in failing hearts: a new porcine model. Circulation 103: 1570-1576, 2001.
32. Zhang J, Merkle H, Hendrich K, Garwood M, From AH, Ugurbil K, Bache RJ. Bioenergetic abnormalities associated with severe left ventricular hypertrophy. J Clin Invest 92: 993-1003, 1993.